Judith Kelleher-Andersson
Fondateur chez NeuroNascent, Inc.
Profil
Judith Kelleher-Andersson is the founder.
She founded NeuroNascent, Inc. in 2004 and currently holds the title of President, Chief Executive Officer & Director.
She has also held former positions as Director-Drug Development & Research at RespireRx Pharmaceuticals, Inc., Centaur Pharmaceuticals, Inc., and Seneca Biopharma, Inc. Dr. Kelleher-Andersson has a doctorate degree from the University of Missouri, an undergraduate degree from St. Anselm College, and a graduate degree from the University of California, Berkeley.
Postes actifs de Judith Kelleher-Andersson
| Sociétés | Poste | Début |
|---|---|---|
NeuroNascent, Inc.
 NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Fondateur | 01/05/2004 |
Anciens postes connus de Judith Kelleher-Andersson
| Sociétés | Poste | Fin |
|---|---|---|
| Centaur Pharmaceuticals, Inc. | Directeur Technique/Scientifique/R&D | - |
| RESPIRERX PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | - |
| PALISADE BIO, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Judith Kelleher-Andersson
| University of Missouri | Doctorate Degree |
| St. Anselm College | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Centaur Pharmaceuticals, Inc. | Health Technology |
NeuroNascent, Inc.
NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |